MURRAY WITTNER, M.D., Ph.D.; KENNETH S. ROWIN, M.D.; HERBERT B. TANOWITZ, M.D.; JEAN F. HOBBS, M.D.; SIMONE SALTZMAN, M.D.; BARRY WENZ, M.D.; ROBERT HIRSCH, M.D.; EMILY CHISHOLM; GEORGE R. HEALY, Ph.D.
We describe babesiosis transmitted by transfusion. The infected blood donor was identified and a minimum period of infectivity of the donor's blood was established. We report a new modality for chemotherapy consisting of quinine plus clindamycin, and a new endemic focus for this zoonosis on Fire Island, New York. There are insufficient data to establish a reasonably safe period after which visitors and residents of Babesia-endemic foci can become blood donors. Screening of such persons by a rapid serologic test, such as the ELISA or immunofluorescent antibody tests, is suggested.
WITTNER M, ROWIN KS, TANOWITZ HB, HOBBS JF, SALTZMAN S, WENZ B, et al. Successful Chemotherapy of Transfusion Babesiosis. Ann Intern Med. ;96:601–604. doi: 10.7326/0003-4819-96-5-601
Download citation file:
Published: Ann Intern Med. 1982;96(5):601-604.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use